research TYK2 Inhibition with Deucravacitinib Improves Clinical Outcomes and Resolves Interferon-Driven Inflammation in Lichen Planopilaris
Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.





Incomplete name
Saint-Rémy-de-Provence, France
Incomplete name
Macedonia, OH, United States
Incomplete name
Stow, OH, United States
Incomplete name
Westport, CT, United States
Incomplete name
Grand Rapids, MI, United States
Valencia, Comunitat Valenciana, Spain